Pfizer | Financial Buzz

Investing News Life Style Market News Medical Use Pharmaceutical Technology The Market Buzz Your Environment

Oxford-AstraZeneca Covid-19 Vaccine Approved in the U.K

Rebecca Urena12/30/202012/30/2020

3312

The United Kingdom approved AstraZeneca’s (OTCMKTS: AZNCF) – the Oxford University’s coronavirus vaccine on Wednesday, becoming the first country to do so. The vaccine is said to be a...

Biotechnology Healthcare Investing News Market News Technology The Market Buzz

Myovant Sciences Stock Rises After Pfizer Collaboration

Danny Abramov12/28/2020

3791

Myovant Sciences Ltd. (NYSE: MYOV) stock jumped more than 26% after the clinical-stage biopharmaceutical company announced a collaboration with Pfizer Inc. (NYSE: PFE) to develop and commercialize relugolix – a once-daily, oral gonadotropin-releasing hormone (GnRH)...

Biotechnology Healthcare Investing News Life Style Market News Technology The Market Buzz Travel Your Environment

United Transports Covid Vaccines Within Passenger Planes

Rebecca Urena12/15/2020

2600

United Airlines (NASDAQ: UAL) announced Tuesday that it has begun transporting coronavirus vaccines in the United States within its passenger aircrafts. A short period of time after U.S officials...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Technology The Market Buzz Your Environment

AstraZeneca’s Oxford Coronavirus Vaccine Proven to be Effective and Affordable

Rebecca Urena11/23/2020

16424

AstraZeneca (OTCMKTS: AZNCF), the Swedish pharmaceutical, along with the University of Oxford have developed a trial coronavirus vaccine that is being praised for being “highly” protective. Ultimately, the vaccine...

Biotechnology Healthcare Market News Technology The Market Buzz

Pfizer and BioNTech Report that Phase 3 Study of COVID-19 Vaccine Candidate Meets All Primary Efficacy Endpoints

Danny Abramov11/18/202011/18/2020

16352

Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) made another announcement regarding their vaccine candidate. After conducting the final efficacy analysis in their ongoing Phase 3 study, their...

Investing News Life Style Market News Technology The Market Buzz Travel Your Environment

United Airlines to Add 1,400 Thanksgiving Flights

Rebecca Urena11/09/2020

8732

United Airlines (NASDAQ: UAL) announced Monday it intends to increase flights throughout thanksgiving week as it expects to have its busiest week since March. Amid positive results from trial...

Biotechnology Healthcare Market News Technology The Market Buzz

Pfizer and BioNTech SE Announce that COVID-19 Vaccine Candidate is 90% Effective

Danny Abramov11/09/202011/09/2020

9272

Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) announced major news on Monday regarding their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2. The vaccine candidate has demonstrated evidence of efficacy against COVID-19...

Biotechnology Healthcare Investing News Life Style Market News Your Environment

Moderna Anticipates to Have Coronavirus Vaccine Answers by November

Rebecca Urena09/17/202009/17/2020

3461

Moderna’s (NASDAQ: MRNA) CEO, Stephane Bancel, announced Thursday that the company should have an answer as to whether its coronavirus vaccine is successful or not by November. “If the...

Investing News Market News Technology

BioNTech SE and Pfizer Inc. announced initial data from their ongoing German Phase ½ COVID-19 Vaccine Study

Danny Abramov07/20/2020

4313

BioNTech SE (NASDAQ: BNTX) and Pfizer Inc. (NYSE: PFE) announced initial data from their ongoing German Phase 1/2, open-label, non-randomized, non-placebo-controlled, dose-escalation trial, that is part of the global...

Healthcare Investing News Market News

Pfizer and Wellcome Launch Surveillance Program to Monitor Rising Danger of Antimicrobial Resistance in Sub-Saharan Africa

Danny Abramov06/24/2020

3654

Pfizer Inc. (NYSE: PFE) and Wellcome announced Wednesday the launch of the Surveillance Partnership to Improve Data for Action on Antimicrobial Resistance (SPIDAAR), a new multi-year, public-private research collaboration...

Tag: Pfizer